Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cyanotech

This article was originally published in The Tan Sheet

Executive Summary

Natural Products marketer records sales of $3.0 mil. for the company's fiscal 2004 third quarter ended Dec. 31, an 22% increase over the prior-year period's sales, Cyanotech announced early this month. Gross profit margin for the third quarter was 39%, a 10% increase compared to third quarter of 2002, resulting from heightened bulk sales of the natural astaxanthin products NatuRose and BioAstin. Though sales of Spirulina Pacifica remained relatively flat, the company succeeded in increasing production of the microalgae...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS096503

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel